Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BZAINYSE:ENPCNASDAQ:LOANNASDAQ:OACC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBZAIBlaize$2.03$2.52$1.70▼$19.25$206.42M0.12636,358 shs326,234 shsENPCExecutive Network Partnering$5.74+3.6%$5.34$8.46▼$10.24$241.16M-0.04245,839 shs343,823 shsLOANManhattan Bridge Capital$5.20+1.1%$5.28$4.74▼$6.05$59.43M0.3318,469 shs5,478 shsOACCOaktree Acquisition Corp. III Life Sciences$10.44+0.1%$10.28$9.95▼$10.85$234.12MN/A118,095 shs305,723 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBZAIBlaize-11.74%-7.73%-20.70%-44.08%+202,999,900.00%ENPCExecutive Network Partnering0.00%-0.54%+12.15%-7.97%-15.68%LOANManhattan Bridge Capital0.00%+0.78%0.00%-7.87%-2.28%OACCOaktree Acquisition Corp. III Life Sciences+0.29%-0.48%+1.36%+4.09%+1,042,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBZAIBlaizeN/AN/AN/AN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/AN/AN/AN/ALOANManhattan Bridge Capital1.7176 of 5 stars0.03.01.70.02.61.71.3OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBZAIBlaize 3.00Buy$5.83187.36% UpsideENPCExecutive Network Partnering 0.00N/AN/AN/ALOANManhattan Bridge Capital 0.00N/AN/AN/AOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LOAN, BZAI, OACC, and ENPC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$3.00 ➝ $3.004/22/2025BZAIBlaizeRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$3.004/8/2025BZAIBlaizeCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$4.50(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBZAIBlaize$458K450.70N/AN/AN/A∞ENPCExecutive Network PartneringN/AN/A$0.02 per share268.01($0.20) per shareN/ALOANManhattan Bridge Capital$7.31M8.13$0.45 per share11.59$3.75 per share1.39OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBZAIBlaizeN/AN/A0.00∞N/AN/AN/AN/AN/AENPCExecutive Network Partnering$1.47MN/A0.004.01N/AN/A-74.23%-2.27%N/ALOANManhattan Bridge Capital$5.48M$0.4710.60∞N/A56.93%13.06%7.75%7/21/2025 (Estimated)OACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest LOAN, BZAI, OACC, and ENPC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025BZAIBlaizeN/A-$0.29N/A-$1.61N/AN/A4/24/2025Q1 2025LOANManhattan Bridge Capital$0.12$0.12N/A$0.12N/A$2.27 million3/12/2025Q4 2024LOANManhattan Bridge Capital$0.12$0.11-$0.01$0.11N/A$2.36 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBZAIBlaizeN/AN/AN/AN/AN/AENPCExecutive Network PartneringN/AN/AN/AN/AN/ALOANManhattan Bridge Capital$0.468.85%-1.75%97.87%1 YearsOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ALatest LOAN, BZAI, OACC, and ENPC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/21/2025LOANManhattan Bridge Capitalquarterly$0.11508.5%7/8/20257/8/20257/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBZAIBlaizeN/AN/AN/AENPCExecutive Network PartneringN/A0.020.02LOANManhattan Bridge CapitalN/A2.582.58OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBZAIBlaize97.12%ENPCExecutive Network Partnering88.58%LOANManhattan Bridge Capital21.84%OACCOaktree Acquisition Corp. III Life SciencesN/AInsider OwnershipCompanyInsider OwnershipBZAIBlaize68.50%ENPCExecutive Network Partnering0.17%LOANManhattan Bridge Capital24.50%OACCOaktree Acquisition Corp. III Life SciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBZAIBlaizeN/A101.68 million32.00 millionN/AENPCExecutive Network Partnering142.01 million41.94 millionNot OptionableLOANManhattan Bridge Capital611.44 million8.64 millionOptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.43 millionN/AN/ALOAN, BZAI, OACC, and ENPC HeadlinesRecent News About These CompaniesToronto Dominion Bank Purchases New Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)May 22, 2025 | marketbeat.comTENOR CAPITAL MANAGEMENT Co. L.P. Invests $2.99 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)May 20, 2025 | marketbeat.comSculptor Capital LP Makes New $2.49 Million Investment in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)May 19, 2025 | marketbeat.comLighthouse Investment Partners LLC Invests $3.04 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)May 16, 2025 | marketbeat.com195,292 Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Acquired by K2 Principal Fund L.P.May 13, 2025 | marketbeat.comAQR Arbitrage LLC Makes New Investment in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)May 3, 2025 | marketbeat.comShaolin Capital Management LLC Acquires Shares of 550,000 Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)April 29, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLOAN, BZAI, OACC, and ENPC Company DescriptionsBlaize NASDAQ:BZAI$2.03 0.00 (0.00%) As of 04:00 PM EasternBlaize® has created a transformative new compute solution that unites silicon and software to optimize AI from the edge to the core. We’re partnering with customers to transform their products so they can deliver better experiences and better lives.Executive Network Partnering NYSE:ENPC$5.74 +0.20 (+3.61%) As of 05/27/2025Executive Network Partnering Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar partnering transaction with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.Manhattan Bridge Capital NASDAQ:LOAN$5.20 +0.06 (+1.07%) Closing price 03:57 PM EasternExtended Trading$5.15 -0.04 (-0.87%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Manhattan Bridge Capital, Inc., a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. The company offers short-term, secured, and non-banking loans to real estate investors to fund acquisition, renovation, rehabilitation, or development of residential or commercial properties. Its loans are secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 1989 and is headquartered in Great Neck, New York.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.44 +0.01 (+0.10%) As of 03:51 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
